HPV-Related Carcinoma

Oncology
3
Pipeline Programs
3
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
2
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Transgene
TransgeneFrance - Illkirch-Graffenstaden
1 program
1
TG4001Phase 1/2
M&
Merck & Co.RAHWAY, NJ
1 program
1
TG4001Phase 1/2
ImmunityBio
ImmunityBioSAN DIEGO, CA
1 program
1
IBRX-042Phase 11 trial
Active Trials
NCT05976828Active Not Recruiting12Est. Aug 2033

Trial Timeline

Clinical trial activity over time

2024
2025
2026
2027
2028
2029
2030
2031
ImmunityBioIBRX-042

Clinical Trials (1)

Total enrollment: 12 patients across 1 trials

NCT05976828ImmunityBioIBRX-042

IBRX-042 In Participants With HPV-Associated Tumors

Start: Jun 2024Est. completion: Aug 203312 patients
Phase 1Active Not Recruiting

Related Jobs in Oncology

Senior Research Associate, Immuno-Oncology

SystImmune
1h ago
$60K - $85K/yr

Research Associate I/II, Immuno-Oncology

SystImmune
1h ago

Office Administrator

SystImmune
1h ago
$60K - $80K/yr

Scientist/Sr Scientist

TwoStep Therapeutics
San Carlos
1h ago

Senior Medical Project Manager (m/f/d)

Mindpeak
Hamburg
1h ago

Working Student Active Sourcing Support (m/f/d)

Mindpeak
Hamburg
1h ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

Related Indications

Breast Cancer(530)Non-small Cell Lung Cancer(373)Prostate Cancer(371)Multiple Myeloma(244)Advanced Solid Tumors(221)Acute Myeloid Leukemia(204)Cancer(187)Neoplasms(173)Colorectal Cancer(166)Advanced Solid Tumor(165)